In the univariate model, WHO grade, IDH status, 1p/19q codeletion, primary therapy outcome, age, histological type, and TRIM6 expression were all significantly associated with OS in Gliomas (Table 2, all p < 0.05). This evidence concerns the gene TRIM6 and central nervous system cancer.